Purchases and Sales Made in Q3 2023 in Genetic Technologies LTD (GENE)
This table provides information about the institutional ownership of Genetic Technologies LTD (GENE) during Q3 2023. The information is specifically focused on institutions that hold shares of GENETIC TECHNOLOGIES LTD.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2023
Q3 2023
|
Scarborough Advisors, LLC
Annapolis, MD |
BUY
|
- |
538K+ 5054.84% |
$376K - $500K
|
548K
$422K
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
938+ 6.29% |
$657 - $872
|
15.8K
$12.2K
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-700- 0.79% |
$490 - $651
|
87.7K
$67.5K
|
|
|
Nov 30, 2023
Q3 2023
|
Scarborough Advisors, LLC
Annapolis, MD |
SELL
|
- |
-538K- 98.06% |
$376K - $500K
|
10.6K
$8.19K
|